Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Abuse of New Psychoactive Substances: Threats and Solutions
Michael H. Baumann, Nora D. Volkow
Neuropsychopharmacology (2015) Vol. 41, Iss. 3, pp. 663-665
Open Access | Times Cited: 56

Showing 1-25 of 56 citing articles:

Synthetic Cathinone and Cannabinoid Designer Drugs Pose a Major Risk for Public Health
Aviv Weinstein, Paola Rosca, Liana Fattore, et al.
Frontiers in Psychiatry (2017) Vol. 8
Open Access | Times Cited: 181
Neuropharmacology of 3,4-Methylenedioxypyrovalerone (MDPV), Its Metabolites, and Related Analogs
Michael H. Baumann, Mohammad O. Bukhari, Kurt Lehner, et al.
Current topics in behavioral neurosciences (2016), pp. 93-117
Open Access | Times Cited: 122
Structure-Activity Relationships of Substituted Cathinones, with Transporter Binding, Uptake, and Release
Amy J. Eshleman, Katherine M. Wolfrum, John F. Reed, et al.
Journal of Pharmacology and Experimental Therapeutics (2016) Vol. 360, Iss. 1, pp. 33-47
Open Access | Times Cited: 116
Overview of Monoamine Transporters
Shaili Aggarwal, Ole V. Mortensen
Current Protocols in Pharmacology (2017) Vol. 79, Iss. 1
Open Access | Times Cited: 95
A deep generative model enables automated structure elucidation of novel psychoactive substances
Michael A. Skinnider, Fei Wang, Daniel Pasin, et al.
Nature Machine Intelligence (2021) Vol. 3, Iss. 11, pp. 973-984
Closed Access | Times Cited: 57
New psychoactive substances of natural origin: A brief review
Ling-Yi Feng, Altansuvd Battulga, Eunyoung Han, et al.
Journal of Food and Drug Analysis (2017) Vol. 25, Iss. 3, pp. 461-471
Open Access | Times Cited: 79
Phase I metabolites of mephedrone display biological activity as substrates at monoamine transporters
Felix P. Mayer, Laurin Wimmer, Ora Dillon‐Carter, et al.
British Journal of Pharmacology (2016) Vol. 173, Iss. 17, pp. 2657-2668
Open Access | Times Cited: 67
The Novel Psychoactive Substances in the UK Project: empirical and conceptual review work to produce research recommendations
Noreen Dadirai Mdege, Nick Meader, Charlie Lloyd, et al.
Public Health Research (2017) Vol. 5, Iss. 4, pp. 1-138
Open Access | Times Cited: 65
The Isoxazole Ring and Its N‐Oxide: A Privileged Core Structure in Neuropsychiatric Therapeutics
George Pairas, Fereniki Perperopoulou, Petros G. Tsoungas, et al.
ChemMedChem (2017) Vol. 12, Iss. 6, pp. 408-419
Closed Access | Times Cited: 53
Sample Mining and Data Mining: Combined Real‐Time and Retrospective Approaches for the Identification of Emerging Novel Psychoactive Substances
Alex J. Krotulski, Susan Jansen Varnum, Barry K. Logan
Journal of Forensic Sciences (2019) Vol. 65, Iss. 2, pp. 550-562
Closed Access | Times Cited: 45
When an obscurity becomes trend: social-media descriptions of tianeptine use and associated atypical drug use
Kirsten E. Smith, Jeffrey M. Rogers, Justin C. Strickland, et al.
The American Journal of Drug and Alcohol Abuse (2021) Vol. 47, Iss. 4, pp. 455-466
Open Access | Times Cited: 38
Festivals following the easing of COVID-19 restrictions: Prevalence of new psychoactive substances and illicit drugs
Nikolaos I. Rousis, Richard Bade, I. Romero, et al.
Environment International (2023) Vol. 178, pp. 108075-108075
Open Access | Times Cited: 14
Evaluating cross-reactivity of new psychoactive substances (NPS) in human whole blood by enzyme-linked immunosorbent assay (ELISA)
Grace Cieri, Amanda L A Mohr, Rebecca Mastrovito, et al.
Journal of Analytical Toxicology (2024) Vol. 48, Iss. 3, pp. 191-196
Closed Access | Times Cited: 5
Drug checking identifies counterfeit alprazolam tablets
Samuel Tobias, Aaron M. Shapiro, Cameron J. Grant, et al.
Drug and Alcohol Dependence (2020) Vol. 218, pp. 108300-108300
Closed Access | Times Cited: 37
Differential effects of synthetic psychoactive cathinones and amphetamine stimulants on the gut microbiome in mice
Mariana Angoa‐Pérez, Branislava Zagorac, Andrew D. Winters, et al.
PLoS ONE (2020) Vol. 15, Iss. 1, pp. e0227774-e0227774
Open Access | Times Cited: 34
Cognitive deficits and neurotoxicity induced by synthetic cathinones: is there a role for neuroinflammation?
Jonna M. Leyrer‐Jackson, Erin K. Nagy, M. Foster Olive
Psychopharmacology (2018) Vol. 236, Iss. 3, pp. 1079-1095
Open Access | Times Cited: 33
Bath salts and polyconsumption: in search of drug-drug interactions
Ana Belén López-Rodríguez, María‐Paz Viveros
Psychopharmacology (2019) Vol. 236, Iss. 3, pp. 1001-1014
Closed Access | Times Cited: 31
Development and validation of a rapid LC‐MS/MS method for the detection of 182 novel psychoactive substances in whole blood
Arianna Giorgetti, Rossella Barone, Guido Pelletti, et al.
Drug Testing and Analysis (2021) Vol. 14, Iss. 2, pp. 202-223
Open Access | Times Cited: 26
A Review on Spike and Recovery Method in Analytical Method Development and Validation
Diksha Thakur, Neeti Prakash Dubey, Rajvinder Singh
Critical Reviews in Analytical Chemistry (2022) Vol. 54, Iss. 7, pp. 2053-2071
Closed Access | Times Cited: 17
Deep Learning-Enabled MS/MS Spectrum Prediction Facilitates Automated Identification Of Novel Psychoactive Substances
Fei Wang, Daniel Pasin, Michael A. Skinnider, et al.
Analytical Chemistry (2023) Vol. 95, Iss. 50, pp. 18326-18334
Open Access | Times Cited: 10
AI Methods for New Psychoactive Substance (NPS) Design and Analysis
Enrico Greco
Analytica—A Journal of Analytical Chemistry and Chemical Analysis (2025) Vol. 6, Iss. 2, pp. 17-17
Open Access
Utility of Nonhuman Primates in Substance Use Disorders Research
Matthew L. Banks, Paul W. Czoty, S. Stevens Negus
ILAR Journal (2017) Vol. 58, Iss. 2, pp. 202-215
Open Access | Times Cited: 27
The synthetic cathinones, butylone and pentylone, are stimulants that act as dopamine transporter blockers but 5-HT transporter substrates
Kusumika Saha, Yang Li, Marion Holy, et al.
Psychopharmacology (2018) Vol. 236, Iss. 3, pp. 953-962
Open Access | Times Cited: 24
α-PPP and its derivatives are selective partial releasers at the human norepinephrine transporter
Julian Maier, Laurin Rauter, Deborah Rudin, et al.
Neuropharmacology (2021) Vol. 190, pp. 108570-108570
Open Access | Times Cited: 20
Eutylone and Its Structural Isomers Interact with Monoamine Transporters and Induce Locomotor Stimulation
Grant C. Glatfelter, Donna Walther, Michael Evans‐Brown, et al.
ACS Chemical Neuroscience (2021) Vol. 12, Iss. 7, pp. 1170-1177
Open Access | Times Cited: 18
Page 1 - Next Page

Scroll to top